Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q416232> ?p ?o }
Showing triples 1 to 77 of
77
with 100 triples per page.
- Q416232 subject Q52376.
- Q416232 subject Q7579524.
- Q416232 subject Q7930599.
- Q416232 subject Q8217320.
- Q416232 subject Q8852225.
- Q416232 subject Q8949762.
- Q416232 subject Q9052323.
- Q416232 abstract "Prasugrel (trade name Effient in the US and India, and Efient in the EU) is a pharmaceutical drug that acts as a platelet inhibitor and is used to prevent thrombosis (blood clotting). It was developed by Daiichi Sankyo Co. and produced by Ube and currently marketed in the United States in cooperation with Eli Lilly and Company.Prasugrel was approved for use in Europe in February 2009, and in the US in July 2009, for the reduction of thrombotic cardiovascular events (including stent thrombosis) in people with acute coronary syndrome (ACS) who are to be managed with percutaneous coronary intervention (PCI).".
- Q416232 atcPrefix "B01".
- Q416232 atcSuffix "AC22".
- Q416232 casNumber "150322-43-3".
- Q416232 casSupplemental "(hydrochloride)".
- Q416232 chEBI "87715".
- Q416232 drugbank "DB06209".
- Q416232 fdaUniiCode "34K66TBT99".
- Q416232 iupacName "(RS)-5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-".
- Q416232 iupacName "tetrahydrothieno[3,2-c]pyridin-2-yl acetate".
- Q416232 pubchem "6918456".
- Q416232 thumbnail Prasugrel_racemic.svg?width=300.
- Q416232 wikiPageWikiLink Q101026.
- Q416232 wikiPageWikiLink Q1129007.
- Q416232 wikiPageWikiLink Q12152.
- Q416232 wikiPageWikiLink Q12252367.
- Q416232 wikiPageWikiLink Q1325542.
- Q416232 wikiPageWikiLink Q1426491.
- Q416232 wikiPageWikiLink Q14864419.
- Q416232 wikiPageWikiLink Q14912267.
- Q416232 wikiPageWikiLink Q14916187.
- Q416232 wikiPageWikiLink Q14916330.
- Q416232 wikiPageWikiLink Q18216.
- Q416232 wikiPageWikiLink Q2008344.
- Q416232 wikiPageWikiLink Q2032041.
- Q416232 wikiPageWikiLink Q214514.
- Q416232 wikiPageWikiLink Q260121.
- Q416232 wikiPageWikiLink Q261327.
- Q416232 wikiPageWikiLink Q266018.
- Q416232 wikiPageWikiLink Q3074941.
- Q416232 wikiPageWikiLink Q410237.
- Q416232 wikiPageWikiLink Q418750.
- Q416232 wikiPageWikiLink Q420060.
- Q416232 wikiPageWikiLink Q420571.
- Q416232 wikiPageWikiLink Q421704.
- Q416232 wikiPageWikiLink Q467717.
- Q416232 wikiPageWikiLink Q4677569.
- Q416232 wikiPageWikiLink Q52376.
- Q416232 wikiPageWikiLink Q603741.
- Q416232 wikiPageWikiLink Q632240.
- Q416232 wikiPageWikiLink Q6591687.
- Q416232 wikiPageWikiLink Q669441.
- Q416232 wikiPageWikiLink Q686886.
- Q416232 wikiPageWikiLink Q721432.
- Q416232 wikiPageWikiLink Q7394928.
- Q416232 wikiPageWikiLink Q7579524.
- Q416232 wikiPageWikiLink Q7930599.
- Q416232 wikiPageWikiLink Q8217320.
- Q416232 wikiPageWikiLink Q879952.
- Q416232 wikiPageWikiLink Q8852225.
- Q416232 wikiPageWikiLink Q8949762.
- Q416232 wikiPageWikiLink Q9052323.
- Q416232 wikiPageWikiLink Q907001.
- Q416232 atcPrefix "B01".
- Q416232 atcSuffix "AC22".
- Q416232 casNumber "150322".
- Q416232 chebi "87715".
- Q416232 drugbank "DB06209".
- Q416232 iupacName "-5".
- Q416232 iupacName "tetrahydrothieno[3,2-c]pyridin-2-yl acetate".
- Q416232 pubchem "6918456".
- Q416232 unii "34".
- Q416232 type ChemicalSubstance.
- Q416232 type Drug.
- Q416232 type ChemicalObject.
- Q416232 type Thing.
- Q416232 type Q8386.
- Q416232 comment "Prasugrel (trade name Effient in the US and India, and Efient in the EU) is a pharmaceutical drug that acts as a platelet inhibitor and is used to prevent thrombosis (blood clotting). It was developed by Daiichi Sankyo Co.".
- Q416232 label "Prasugrel".
- Q416232 depiction Prasugrel_racemic.svg.